Latest filing published 31 Jul 2026 for Janux Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of David Alan Campbell in Janux Therapeutics, Inc. The record holds 10 filings, for trades running from 27 September 2024 to 31 July 2026.
Sales make up the whole of the open-market record (7 sales, €5.1M). Outside the open market, there are 1 share grant and 1 option exercise. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 31 July 2026, reports a transaction in Janux Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations